Aytu Biopharma (AYTU) Change in Cash (2010 - 2026)
Aytu Biopharma (AYTU) posted quarterly Change in Cash of -$3.3 million for Q1 2026, down 48.76% year-over-year from -$6.5 million in Q1 2025, and down 27.06% quarter-over-quarter from -$2.6 million in Q4 2025.
Aytu Biopharma (AYTU) Change in Cash (2010 - 2026) Analysis & Trends
Aytu Biopharma (AYTU) has reported Change in Cash for 17 consecutive years, with -$3.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Cash fell 48.76% year-over-year to -$3.3 million; the TTM figure through Mar 2026 stood at $8.5 million (up 638.25% YoY), while the FY2025 annual figure was $10.9 million, up 467.44% from the prior year.
- Change in Cash eased to -$3.3 million in Q1 2026 per AYTU's latest filing, from -$2.6 million in the prior quarter.
- Across five years, Change in Cash topped out at $12.8 million in Q2 2025 and bottomed at -$8.3 million in Q2 2022.
- Historically, Change in Cash has averaged -$503647.1 across 5 years, with a median of -$322000.0 in 2023.
- On a YoY basis, Change in Cash climbed as much as 5094.72% in 2025 and fell as far as 1063.2% in 2025.
- Aytu Biopharma's Change in Cash stood at -$4.3 million in 2022, then soared by 89.91% to -$435000.0 in 2023, then surged by 166.67% to $290000.0 in 2024, then tumbled by 998.28% to -$2.6 million in 2025, then fell by 27.06% to -$3.3 million in 2026.
- Business Quant data shows AYTU's Change in Cash at -$3.3 million in Q1 2026, -$2.6 million in Q4 2025, and $1.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.96 Bn | 43.00 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.23 Bn | 39.58 Bn | 2.15 Bn | -86.00 Mn |
| 3 | Zoetis | 31.76 Bn | 30.08 Bn | 1.05 Bn | -465.00 Mn |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn | -881.03 Mn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 523.50 Mn |
| 6 | Viatris | 18.69 Bn | 17.81 Bn | 1.46 Bn | -915.70 Mn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | 64.40 Mn |
| 8 | Elanco Animal Health | 11.78 Bn | 11.25 Bn | 798.00 Mn | 102.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Aytu Biopharma | 24.70 Mn | -2.01 Mn | 7.60 Mn | -3.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.31 Mn |
| Dec 31, 2025 | -2.61 Mn |
| Sep 30, 2025 | 1.68 Mn |
| Jun 30, 2025 | 12.78 Mn |
| Mar 31, 2025 | -2.23 Mn |
| Dec 31, 2024 | 290,000.00 |
| Sep 30, 2024 | 102,000.00 |
| Jun 30, 2024 | 246,000.00 |
| Mar 31, 2024 | 231,000.00 |
| Dec 31, 2023 | -435,000.00 |
| Sep 30, 2023 | -3.02 Mn |
| Jun 30, 2023 | 3.81 Mn |
| Mar 31, 2023 | -322,000.00 |
| Dec 31, 2022 | -4.31 Mn |
| Sep 30, 2022 | 4.45 Mn |
| Jun 30, 2022 | -8.25 Mn |
| Mar 31, 2022 | -7.66 Mn |
| Dec 31, 2021 | -5.28 Mn |
| Sep 30, 2021 | -9.34 Mn |
| Jun 30, 2021 | 3.11 Mn |